MOBILE VET CLINIC BUSINESS PLAN
I. Executive Summary
Company Description
Hearth & Hound Mobile Veterinary draws its name from "hearth" (home comfort) and "hound" (companion animals). We operate in the U.S. veterinary services sector as a mobile clinical provider launching in 2026. Our core services are in-home wellness exams, preventive care, diagnostics, urgent minor procedures, and small soft-tissue surgery delivered from a fleet of fully equipped mobile clinics. We schedule visits, manage medical records, stock pharmaceuticals, and dispatch licensed DVMs and veterinary technicians to clients' homes to reduce stress for pets and save owners time.
What sets us apart is a clinic-grade mobile platform plus a patient-first service model focused on affluent suburban and urban neighborhoods where convenience and low-stress care command premium pricing. Short-term goals: launch operations in Q2 2026, deploy an initial fleet of mobile units, and reach positive cash flow in year two. Long-term goals: scale via added specialty practitioners and 50+ units across multiple U.S. markets within five years while maintaining clinical quality and >80% net promoter scores.
Problem
Traditional veterinary visits produce significant stress for pets and owners, including white coat syndrome, which can skew diagnostic readings and delay care. Crowded waiting rooms and travel increase anxiety and lead owners to defer or skip wellness exams.
Multi-pet households, seniors, and homebound owners face transport and mobility barriers that limit access to essential care, and the market currently lacks sufficient home-based clinical solutions to close this access gap.
Solution
Pet owners face stress, time, and transport barriers that reduce preventive care and worsen outcomes; our mobile veterinary clinic delivers full clinic-grade care at the pet’s home, reducing anxiety, saving owners time, and restoring access for seniors and those without transport. One line: we bring full veterinary care to the pet’s familiar environment, reducing stress and saving owners time.
Core capabilities: wellness exams and vaccinations, minor on-board surgery, digital x-ray, same-visit blood analysis, longer one-on-one appointments, and home-based treatment to cut commute and clinic stress.
Mission Statement
We deliver stress-free, high-quality veterinary care in pets' homes to improve access and reduce stress for animals and owners. We commit to clinical excellence, compassionate service, and ongoing innovation to strengthen the pet-owner bond and improve long-term pet health. We aim to set the gold standard for mobile veterinary medicine by eliminating barriers to care and providing focused attention on every house call.
Key Success Factors
Success depends on operational efficiency, staffing, partnerships, and a consistent fear-free patient experience.
-
85% practitioner utilization by 2030 to maximize billable treatments per clinician.
-
Route optimization to reduce fuel and maintenance costs and increase daily visits.
-
Recruitment and retention of licensed vets and technicians via competitive pay and a unique work environment.
-
Referral partnerships with local pet businesses and emergency hospitals to sustain client pipeline.
-
Fear-free patient experience to drive repeat visits and long-term brand loyalty.
Financial Summary
Brief financial snapshot for the Executive Summary.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | | | |
Projected EBITDA | -$104,000 | $207,000 | $550,000 |
Expected ROI | IRR 4.04% / ROE 4.32 | IRR 4.04% / ROE 4.32 | IRR 4.04% / ROE 4.32 |
Financial requirements: maintain minimum cash of $400,000 (minimum cash month Jan‑2027); payback period 38 months; breakeven in Feb‑2027.
Overall outlook: negative Year‑1 EBITDA with positive cash runway and rising EBITDA to $550k in Year‑3 and $2.356M by Year‑5.
Funding Requirements
We request $1,000,000 to fund capital spending, working capital, and early go‑to‑market costs to reach breakeven in February 2027.
Categories | Amount, USD |
Product Development | 0 |
Marketing (initial) | 0 |
Operations (fixed & variable) | 0 |
Staffing (initial hires & payroll reserve) | 0 |
CapEx (vehicles, medical tech, diagnostic lab) | 458,000 |
Contingency / additional buffer | 38,000 |
Working capital | 504,000 |
Total funding required | 1,000,000 |
$1,000,000 requested to fund capex, working capital, and early go‑to‑market.
Financial summary: Year 1 EBITDA is projected at -$104,000 with breakeven targeted Feb 1, 2027; EBITDA grows to $207,000 (Year 2), $550,000 (Year 3), and $2,356,000 (Year 5). Maintain a minimum cash reserve of $400,000. Project IRR is 4.04%, ROE is 4.32%, and total payback is 38 months.